HomePEB • NZE
add
Pacific Edge Ltd
Previous close
$0.14
Day range
$0.14 - $0.14
Year range
$0.071 - $0.19
Market cap
113.67M NZD
Avg Volume
192.85K
P/E ratio
-
Dividend yield
-
Primary exchange
NZE
Market news
Financials
Income Statement
Revenue
Net income
| (NZD) | Mar 2024info | Y/Y change |
|---|---|---|
Revenue | 5.64M | -2.51% |
Operating expense | 10.69M | -11.05% |
Net income | -7.14M | 12.88% |
Net profit margin | -126.68 | 10.64% |
Earnings per share | — | — |
EBITDA | -7.75M | 9.33% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (NZD) | Mar 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 50.26M | -35.39% |
Total assets | 65.45M | -28.01% |
Total liabilities | 10.83M | 32.83% |
Total equity | 54.62M | — |
Shares outstanding | 811.27M | — |
Price to book | 2.03 | — |
Return on assets | -30.03% | — |
Return on capital | -33.48% | — |
Cash Flow
Net change in cash
| (NZD) | Mar 2024info | Y/Y change |
|---|---|---|
Net income | -7.14M | 12.88% |
Cash from operations | -5.38M | 7.28% |
Cash from investing | 10.06M | 123.79% |
Cash from financing | -199.50K | 59.90% |
Net change in cash | 4.40M | 284.71% |
Free cash flow | -4.15M | 22.62% |
About
Pacific Edge Limited, based in New Zealand, focuses on cancer diagnostics with a suite of bladder cancer diagnostic tools using genetic biomarkers. The company operates with a head office in Dunedin, New Zealand, and also has an office in Hershey, USA. It is listed on the New Zealand NZX main board stock exchange and is included in the NZX 50 Index. Wikipedia
Founded
2001
Website
Employees
114
